Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw
½ÅÀº¿µ, ±Ç¿µÇõ, ÇãÀÍ, ½Å½ÂÀÏ, Á¤Á¾Çõ,
¼Ò¼Ó »ó¼¼Á¤º¸
½ÅÀº¿µ ( Shin Eun-Young ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±Ç¿µÇõ ( Kwon Young-Hyuk ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
ÇãÀÍ ( Herr Yeek ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
½Å½ÂÀÏ ( Shin Seung-Il ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
Á¤Á¾Çõ ( Chung Jong-Hyuk ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
KMID : 0363020100400020090
Abstract
Purpose: The aim of this study is to report a case of oral bisphosphonate-related osteonecrosis of the jaw (BRONJ) resulting in implant failure.
Methods: A patient suspected of having BRONJ was referred to the Department of Periodontology, Kyung Hee University School of Dentistry for the evaluation and treatment of exposed bone around implants.
Results: The patient, who had been taking oral bisphosphonates (BPs) for about a year, was successfully treated with systemic antibiotics, chlorhexidine mouth rinse, explantation, and surgical debridement of necrotic bone.
Conclusions: The results of this case suggest that a patient taking BPs orally should be treated cautiously. Appropriate management including cessation of BPs and respective dental treatment may reduce the development of BRONJ.
Å°¿öµå
Bisphosphonates;Osteonecrosis;Osteoporosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸